<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[patent protection Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/patent+protection.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to patent protection]]></description>
	<s:counts start="0" returned="20" found="28" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Dyax Corp. Expands Patent Protection for DX-88 in On-Pump Cardiothoracic Surgery]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_July_19/ai_n27315444]]></link>
		<description><![CDATA[CAMBRIDGE, Mass. -- Dyax Corp. (NASDAQ: DYAX) announced today the issuance of a U.S. patent for its lead product candidate DX-88, a non-naturally occurring kallikrein inhibitor, and its uses. U.S. Patent No. 7,235,530 (issued June 26, 2007), relates to the company's DX-88 program in on-pump cardiothoracic surgery CTS, and provides...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 19 Jul 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[patent protection]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[EnXnet Inc. granted patent protection for EnXcase]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn4182/is_20061006/ai_n16773894]]></link>
		<description><![CDATA[EnXnet Inc. has been granted full patent protection for the EnXcase, a self-contained theft prevention CD/DVD case holder. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 06 Oct 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[patent protection]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[SRS Labs Announces Patent Protection of SRS WOW® Now Covers United States, Europe and China; With Newly Granted US and Chinese Patents, SRS Labs Customers Now Enjoy Broad Patent Protection for Popular 3D Audio Enhancement Technique]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_August_2/ai_n26944893]]></link>
		<description><![CDATA[SANTA ANA, Calif. -- SRS Labs Inc. (NASDAQ:SRSL), a leading provider of surround sound, audio and voice technologies, was recently awarded U.S. Patent 7,031,474, entitled "Acoustic correction apparatus," to cover its award-winning SRS WOWR audio enhancement technology. Specifically, the patent covers methods of acoustic compensation for spatial and spectral distortion...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 02 Aug 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/3d.html"><![CDATA[3D]]></category>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[patent protection]]></category>
		<category domain="http://resources.bnet.com/topic/technique.html"><![CDATA[technique]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Ecopia Announces that the USPTO Confirms Patent Protection on ECO-4601's Composition of Matter Claims]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200607/ai_n16536367]]></link>
		<description><![CDATA[Ecopia (TSX: EIA) is pleased to announce that The United States Patent and Trademark Office USPTO has confirmed allowance of US patent application USSN 10/762,107, including notably the composition-of-matter claims directed to Ecopia's lead drug candidate ECO-4601.  In 2005, the USPTO had issued a first Notice of Allowance for...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 13 Jul 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[patent protection]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Hot Stocks to Watch for Friday, April 28, 2006: Patent Protection for Core Drug Discovery and Toxicology Platform!]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200604/ai_n16136053]]></link>
		<description><![CDATA[TheSUBWAY.com announces the following stocks to its Hot Stocks List: Stem Cell Innovations, Inc. (OTC BB: SCLL), Conexant Systems, Inc. (NASDAQ: CNXT), Intuitive Surgical, Inc. (NASDAQ: ISRG), Nektar Therapeutics (NASDAQ: NKTR). ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 28 Apr 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[patent protection]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[TheSUBWAY.com Posts Stock Pick List: Filing for Patent Protection!]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200604/ai_n16137396]]></link>
		<description><![CDATA[TheSUBWAY.com names the following stocks to its Stock Pick List: eWAN1, Inc. (OTC: EWAN), Juniper Networks, Inc. (NASDAQ: JNPR), JDS Uniphase (NASDAQ: JDSU), CIENA Corporation (NASDAQ: CIEN). ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 19 Apr 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[patent protection]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[eFoodSafety.com Inc. Subsidiary Knock-Out Technologies Ltd. Files for Patent Protection on Bird Flu Formulas; Citroxin and Citroxin O2 Secure 'Patent Pending' Status for Formulations]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_April_19/ai_n26834077]]></link>
		<description><![CDATA[SCOTTSDALE, Ariz. -- Patricia Gruden, president/CEO of eFoodSafety.com Inc. (OTCBB: EFSF), announced today that the company's wholly owned subsidiary, Knock-Out Technologies Ltd., has filed with the United States Patent and Trademark Office for patent protection on their bird flu formulations, Citroxin and Citroxin O2.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 19 Apr 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bird+flu.html"><![CDATA[bird flu]]></category>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[patent protection]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[EnXnet, Inc. Expands World Wide Patent Protection to Non-PCT Member, Argentina, for Thindisc Technology]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_March_8/ai_n26787934]]></link>
		<description><![CDATA[TULSA, Okla. -- EnXnet, Inc. (OTCBB:EXNT)(German WKN# AOHMDW) announces it has filed for Patent rights with the Argentinean Patent Office for its ThinDisctm patent filed in March 2005 with the United States Patent Office and internationally under the PCT Patent Cooperation Treaty in February 2006.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 08 Mar 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[patent protection]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Salix Pharmaceuticals Acquires Patent-Protected, Liquid Peg Bowel Cleanser from Norgine; FDA Review Response Due April 2006]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Dec_7/ai_n15899209]]></link>
		<description><![CDATA[RALEIGH, N.C. -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that Norgine B.V. has granted Salix the exclusive rights to sell a patent-protected, liquid PEG bowel cleansing product, NRL944, in the United States. The product is currently under review at the U.S. Food and Drug Administration FDA to obtain marketing approval...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 07 Dec 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[patent protection]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Ecopia Obtains Patent Protection on ECO-4601 from the USPTO]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Dec_7/ai_n15899665]]></link>
		<description><![CDATA[MONTREAL -- Ecopia BioSciences Inc. (TSX:EIA) is pleased to announce it has received a Notice of Allowance from the United States Patent and Trade-mark Office ("USPTO") for a patent application directed to ECO-4601, the Company's lead anticancer compound that is in preparation for its Phase I clinical trials. The allowed...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 07 Dec 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[patent protection]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Ecopia Obtains Patent Protection on ECO-4601 from the USPTO.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200512/ai_n23500347]]></link>
		<description><![CDATA[MONTREAL, QUEBEC, Dec 7, 2005 CCNMatthews via COMTEX -- Ecopia  BioSciences Inc. (TSX:EIA) is pleased to announce it has received a  Notice of Allowance from the United States Patent and Trade-mark Office  ("USPTO") for a patent application   MONTREAL, QUEBEC, Dec 7, 2005 CCNMatthews via COMTEX...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 07 Dec 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/allowance.html"><![CDATA[Allowance]]></category>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[patent protection]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Invisa Announces New Digital Presence Sensing Technology; Invisa Expands Patent Protection]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Sept_27/ai_n15633790]]></link>
		<description><![CDATA[SARASOTA, Fla. -- Invisa, Inc. (OTCBB:INSA), an electronic life safety and security company, announced today that it has filed a new PCT Patent application titled "Digital Capacitive Sensing Device for Security and Safety Applications." The PTC filing is a formal patent application covering inventions protected by a provisional patent filing....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 27 Sep 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[patent protection]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[ALR Technologies Receives Notice From US Patent Office That Patent Protection Covering Several of Their Products Has Been Allowed]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200502/ai_n9512659]]></link>
		<description><![CDATA[ALR Technologies Inc. (OTC BB: ALRT), headquartered in Winston-Salem, NC, announced today it has been notified by the US Patent and Trademark Office that patent protection covering important elements of many of their disease management reminder products has been allowed and will soon issue. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 10 Feb 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[patent protection]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Scan-Optics Files for Patent Protection for SO Series Scanner]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2004_Dec_1/ai_n7585260]]></link>
		<description><![CDATA[MANCHESTER, Conn. -- Scan-Optics, Inc. (OTC BB: SOCR), a leader in information capture and customer service solutions for government, insurance, order fulfillment, proxy, health claims, test scoring and other paper-intensive businesses, today announced that it has filed a provisional application for patent protection covering the novel features of its recently...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 01 Dec 2004 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[patent protection]]></category>
		<category domain="http://resources.bnet.com/topic/scanner.html"><![CDATA[scanner]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Profitable Innovation Without Patent Protection: The Case of Derivatives]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=101929]]></link>
		<description><![CDATA[Investment banks develop their own innovative derivatives to underwrite corporate issues but they cannot preclude other banks from imitating them. However, during the process of underwriting an innovator can learn more than its imitators about the potential clients. Moving first puts him ahead in the learning process. Thus, he develops...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Wed, 01 Sep 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/innovation.html"><![CDATA[Innovation]]></category>
		<category domain="http://resources.bnet.com/topic/derivatives.html"><![CDATA[Derivatives]]></category>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[Patent Protection]]></category>
		<category domain="http://resources.bnet.com/topic/university+of+lausanne.html"><![CDATA[University Of Lausanne]]></category>
		<category domain="http://resources.bnet.com/topic/financial+services.html"><![CDATA[Financial Services]]></category>
		<category domain="http://resources.bnet.com/topic/leadership.html"><![CDATA[Leadership]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
	</item>
	<item>
		<title><![CDATA[FDA Will Grant ILEX's Clofarabine Additional Six-Month Pediatric Exclusivity; Incentive Provides Extended Patent Protection Upon Marketing Approval]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2004_July_21/ai_n6115873]]></link>
		<description><![CDATA[SAN ANTONIO -- ILEXTM Oncology Inc. (Nasdaq:ILXO) announced today that the U.S. Food and Drug Administration FDA will grant six months of extended market exclusivity to clofarabine under the Best Pharmaceuticals for Children Act. Clofarabine is currently under priority review by the FDA for the treatment of refractory or relapsed...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 21 Jul 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/incentive.html"><![CDATA[incentive]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[marketing]]></category>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[patent protection]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Intellectual Property Protection For Fast Evolving Technologies]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=312739]]></link>
		<description><![CDATA[This paper studies the effects of market competition and intellectual property protection emerging technologies such as software. In doing so, this research aims at contributing to the ongoing discussion on the possibility of broadening the scope of patent protection, in the EU, in order to cover many of the newly...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Tue, 25 Mar 2003 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[Patent Protection]]></category>
		<category domain="http://resources.bnet.com/topic/intellectual+property+protection.html"><![CDATA[Intellectual Property Protection]]></category>
		<category domain="http://resources.bnet.com/topic/london+school+of+economics.html"><![CDATA[London School Of Economics]]></category>
		<category domain="http://resources.bnet.com/topic/intellectual+property.html"><![CDATA[Intellectual Property]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
	</item>
	<item>
		<title><![CDATA[Patentable Subject [Anti] Matter]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=77649]]></link>
		<description><![CDATA[In general, man-made inventions and new compositions of matter are proper subjects of patent protection, while products of nature are not. The lawmakers in the United States are in dilemma. The cause for this dilemma stems from the fact that antihydrogen, a newly created element made entirely of antimatter, has...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Wed, 01 Jan 2003 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/duke+university.html"><![CDATA[Duke University]]></category>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[Patent Protection]]></category>
	</item>
	<item>
		<title><![CDATA[Administration proposes pro-generics rule changes.(White House proposes to block brand-name drug companies from filing multiple patent-protection lawsuits)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200210/ai_n13273598]]></link>
		<description><![CDATA[THE WHITE HOUSE proposed new regulations last week that would make  it easier for generic drugs to reach the market by blocking brand-name  pharmaceutical companies from filing multiple patent-protection  lawsuits.       "I'm taking action to clo    THE WHITE HOUSE...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 28 Oct 2002 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/administration.html"><![CDATA[administration]]></category>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[patent protection]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/prescription+drug.html"><![CDATA[prescription drug]]></category>
		<category domain="http://resources.bnet.com/topic/white+house.html"><![CDATA[White House]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Patent protection; Companies battle to defend hard-won discoveries from encroachment.(Rubicon Technology Inc., Cobotics Inc., NanoInk Inc.)(Statistical Data Included)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5253/is_200207/ai_n20188735]]></link>
		<description><![CDATA[NanoInk Inc., a new Chicago-based nanotechnology company, would  like to be the house that patents built, says CEO Chris Anzalone. But  first, it must build a foundation of intellectual property protection  for its high-tech inventions.    The company o  NanoInk Inc., a new Chicago-based...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 08 Jul 2002 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/intellectual+property.html"><![CDATA[intellectual property]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/patent+application.html"><![CDATA[patent application]]></category>
		<category domain="http://resources.bnet.com/topic/patent+protection.html"><![CDATA[patent protection]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
